Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRG2 | P18507 | 7/20 | 0.59 |
| ▸ | GABRB3 | P28472 | 7/20 | 0.59 |
| ▸ | GABRA5 | P31644 | 7/20 | 0.59 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9258726 | 0.86 | GABRG2 (0.55) | GABRG2GABRB3GABRA5 | |
| SCHEMBL9264342 | 0.84 | GABRG2 (0.58) | GABRG2GABRB3GABRA5GABRA1GABRA3 | |
| SCHEMBL9268520 | 0.83 | GABRG2 (0.65) | GABRG2GABRB3GABRA5GABRA1GABRA3 | |
| SCHEMBL9372064 | 0.80 | GABRA1 (0.63) | GABRG2GABRB3GABRA5GABRA1GABRA3 | |
| SCHEMBL9266435 | 0.80 | GABRG2 (0.59) | GABRG2GABRB3GABRA5GABRA1GABRA3 | |
| SCHEMBL9259079 | 0.79 | GABRG2 (0.66) | GABRG2GABRB3GABRA5GABRA1GABRA3 | |
| SCHEMBL9265109 | 0.77 | GABRG2 (0.41) | GABRG2GABRB3GABRA5GABRA1GABRA3 | |
| SCHEMBL4592960 | 0.75 | GABRG2 (1.00) | GABRG2GABRB3GABRA5GABRA1GABRA3 | |
| SCHEMBL9260584 | 0.75 | GABRG2 (0.55) | GABRG2GABRB3GABRA5GABRA1GABRA6 | |
| SCHEMBL10627757 | 0.74 | GABRA1 (0.50) | GABRG2GABRB3GABRA5GABRA1GABRA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5387585-A | Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia | HOFFMANN-LA ROCHE INC. (US) | 1995-02-07 | — | — | US | disclosed |
| EP-0519307-A2 | Tetracyclic Imidazodiazepines | F. HOFFMANN-LA ROCHE AG (CH) | 1992-12-23 | — | — | EP | disclosed |